Search INNV
InnovAge Holding Corp.
Nasdaq · CIK 1834376
Last close8.96
Daily change+0.16 (1.82%)
10 Years gain-62.98%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
INNV · STANDARD
SIC 8000 · Services-Health Services · Fiscal year end 0630
Fundamental
70.2Momentum
58.1Acceleration
58.5Confidence
100.0Annual Revenue7
Quarterly Revenue23
Annual CFO7
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth18.9 / 25
Quality16.8 / 25
Capital Efficiency9.3 / 20
Balance Sheet13.1 / 15
Shareholder Economics8.6 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 4.146 percentage points.
Operating leverageOperating margin improved by 1.6175 percentage points.
FCF turned positiveFree cash flow moved from negative to positive.
ROIC expansionROIC improved by 1.8012 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Key Metrics
Revenue Growth TTM17.27%OK
Revenue CAGR 3Y12.88%OK
Gross Margin21.77%OK
Operating Margin-1.87%OK
FCF Margin5.83%OK
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-7.48%OK
Incremental Operating Margin 3Y12.3%OK
Net Debt / CFO-1.18xOK
Diluted Share Growth 1Y0.2%OK
SBC / Revenue0.78%OK
SBC / FCF13.33%OK
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026 FY Jun 30, 2026 | $989.71M | $227.76M | $2.62M | $64.71M | $50.41M | 23.01% | 0.26% | 5.09% | 1.25% | 135.7M |
| 2026 FY Jun 30, 2025 | $853.70M | $153.64M | -$29.76M | $32.87M | $26.60M | 18% | -3.49% | 3.12% | -11.16% | 135.39M |
| 2025 FY Jun 30, 2024 | $763.86M | $132.06M | -$23.18M | -$36.90M | -$44.81M | 17.29% | -3.03% | -5.87% | -8.62% | 135.9M |
| 2024 FY Jun 30, 2023 | $688.09M | $101.29M | -$49.40M | $20.24M | -$3.12M | 14.72% | -7.18% | -0.45% | -18.85% | 135.59M |
| 2023 FY Jun 30, 2022 | $698.64M | $135.37M | -$4.41M | $27.30M | -$10.94M | 19.38% | -0.63% | -1.57% | -1.61% | 135.52M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $945.90M | sum latest 4 fiscal quarters Revenue | OK | 0001834376-26-000022, 0001834376-25-000074 |
| Revenue Growth TTM | 17.27% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001834376-26-000022, 0001834376-25-000074 |
| Revenue CAGR 3Y | 12.88% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001834376-26-000049 |
| Revenue CAGR 5Y | 9.19% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001834376-26-000049 |
| Gross Profit CAGR 3Y | 31.01% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001834376-26-000049 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0001834376-26-000022, 0001834376-25-000074 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | 0001834376-26-000022, 0001834376-26-000013 |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 21.77% | Gross Profit / Revenue | OK | 0001834376-26-000022, 0001834376-25-000074 |
| Operating Margin | -1.87% | Operating Income / Revenue | OK | 0001834376-26-000022, 0001834376-25-000074 |
| FCF Margin | 5.83% | (CFO - CapEx) / Revenue | OK | 0001834376-26-000022, 0001834376-26-000013 |
| ROIC | -7.48% | NOPAT / Average Invested Capital | OK | 0001834376-26-000022, 0001834376-25-000074 |
| Net Debt / CFO | -1.18x | Net Debt / CFO | OK | 0001834376-26-000022, 0001834376-26-000013 |
| Current Ratio | 1.03x | Current Assets / Current Liabilities | OK | derived |
| Cash / Debt | 2.39x | (Cash + Short-term Investments) / Total Debt | OK | 0001834376-26-000022 |